• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育异常痣的管理:美国皮肤科协会会员调查

Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology.

作者信息

Tripp Jackie M, Kopf Alfred W, Marghoob Ashfaq A, Bart Robert S

机构信息

Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York 10016, USA.

出版信息

J Am Acad Dermatol. 2002 May;46(5):674-82. doi: 10.1067/mjd.2002.121029.

DOI:10.1067/mjd.2002.121029
PMID:12004306
Abstract

BACKGROUND

Opinions concerning the significance of dysplastic nevi and their management vary among dermatologists.

OBJECTIVE

The purpose of this study was to assess how fellows of the American Academy of Dermatology (AAD) perceive and manage dysplastic nevi.

METHODS

Questionnaires were sent to 1216 fellows of the AAD; 456 questionnaires were returned.

RESULTS

Almost all respondents (98%) accept the dysplastic nevus, or atypical mole, as an entity. Seventy-five percent of respondents perform follow-up total cutaneous examinations on all their patients with dysplastic nevi, and another 22% on some of them; 86% usually intend to do total removals when they perform biopsies of dysplastic nevi; 75% use margins of 2 mm or less when removing dysplastic nevi; 49% order baseline total-cutaneous photographs of some or all of their patients with multiple dysplastic nevi, although only 12% do so routinely; 67% prefer to re-excise dysplastic nevi when margins are positive, some using histologic atypia as a criterion; 60% recommend an ophthalmologic examination for at least some of their patients with many dysplastic nevi, although only 3% do so routinely; 12% always recommend cutaneous examinations of blood relatives of their patients with dysplastic nevi and another 81% recommend such examinations for at least some of their patients with dysplastic nevi; 23% use dermoscopy; 99% recommend self-examination; almost 100% recommend sunscreen use and 93%, sun avoidance.

CONCLUSION

Most respondents, in agreement with the literature, accept the concept that patients with dysplastic nevi are at increased risk for melanoma and that methods for prevention and early detection of melanomas are appropriate for these patients.

摘要

背景

皮肤科医生对于发育异常痣的重要性及其处理方法的看法各不相同。

目的

本研究旨在评估美国皮肤科协会(AAD)的成员如何看待和处理发育异常痣。

方法

向1216名AAD成员发送了问卷;共收回456份问卷。

结果

几乎所有受访者(98%)都认可发育异常痣或非典型痣这一概念。75%的受访者会对所有发育异常痣患者进行随访时进行全面皮肤检查,另有22%的受访者会对部分患者进行此类检查;86%的受访者在对发育异常痣进行活检时通常打算将其完全切除;75%的受访者在切除发育异常痣时采用2毫米或更小的切缘;49%的受访者会为部分或所有有多发性发育异常痣的患者拍摄基线全皮肤照片,不过只有12%的受访者会定期这么做;67%的受访者在切缘阳性时更倾向于再次切除发育异常痣,有些人将组织学异型性作为标准;60%的受访者建议至少对部分有多发性发育异常痣的患者进行眼科检查,不过只有3%的受访者会定期这么做;12%的受访者总是建议对发育异常痣患者的血亲进行皮肤检查,另有81%的受访者建议至少对部分发育异常痣患者进行此类检查;23%的受访者使用皮肤镜检查;99%的受访者建议自我检查;几乎100%的受访者建议使用防晒霜,93%的受访者建议避免日晒。

结论

大多数受访者与文献观点一致,认可发育异常痣患者患黑色素瘤的风险增加这一概念,并且认为针对这些患者的黑色素瘤预防和早期检测方法是合适的。

相似文献

1
Management of dysplastic nevi: a survey of fellows of the American Academy of Dermatology.发育异常痣的管理:美国皮肤科协会会员调查
J Am Acad Dermatol. 2002 May;46(5):674-82. doi: 10.1067/mjd.2002.121029.
2
Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins.中度异型性痣切除活检但切缘阳性的皮肤黑色素瘤后续风险。
JAMA Dermatol. 2018 Dec 1;154(12):1401-1408. doi: 10.1001/jamadermatol.2018.3359.
3
Management of Spitz nevi: a survey of dermatologists in the United States.斯皮茨痣的管理:对美国皮肤科医生的一项调查。
J Am Acad Dermatol. 2002 Aug;47(2):224-30. doi: 10.1067/mjd.2002.121031.
4
Histologic processing and reporting of cutaneous pigmented lesions: recommendations based on a survey of 94 dermatopathologists.皮肤色素性病变的组织学处理和报告:基于对 94 位皮肤科病理学家的调查的建议。
J Am Acad Dermatol. 2010 Oct;63(4):661-7. doi: 10.1016/j.jaad.2009.09.047.
5
A nongrading histologic approach to Clark (dysplastic) nevi: A potential to decrease the excision rate.Clark(发育不良)痣的非分级组织学方法:降低切除率的潜力。
J Am Acad Dermatol. 2016 Jan;74(1):68-74. doi: 10.1016/j.jaad.2015.09.030. Epub 2015 Nov 6.
6
Dysplastic nevi and malignant melanoma.发育异常痣与恶性黑色素瘤。
Am Fam Physician. 1990 Aug;42(2):372-85.
7
The dysplastic nevus: recognition and management.发育异常痣:识别与处理
Plast Reconstr Surg. 1988 Feb;81(2):280-9. doi: 10.1097/00006534-198802000-00027.
8
Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.非典型(发育不良)痣:手术切除的结果及与黑色素瘤的关系。
JAMA Dermatol. 2013 Aug;149(8):928-34. doi: 10.1001/jamadermatol.2013.4440.
9
[Dysplastic melanocytic nevus].[发育异常性黑素细胞痣]
Duodecim. 2010;126(21):2492-501.
10
A Multicenter Survey: How Do Transplant Dermatologists Monitor Organ Transplant Recipients With Nevi?一项多中心调查:移植皮肤科医生如何监测患有痣的器官移植受者?
Exp Clin Transplant. 2018 Mar;16 Suppl 1(Suppl 1):198-202. doi: 10.6002/ect.TOND-TDTD2017.P64.

引用本文的文献

1
Predictive Value of Positive Margins in Diagnostic Biopsies of Dysplastic Nevi.发育异常痣诊断性活检中切缘阳性的预测价值
Dermatol Res Pract. 2020 Jan 29;2020:6716145. doi: 10.1155/2020/6716145. eCollection 2020.
2
The so-called dysplastic nevus is not dysplastic at all.所谓的发育异常痣根本就没有发育异常。
Dermatol Pract Concept. 2013 Jan 31;3(1):1-2. doi: 10.5826/dpc.0301a01. Print 2013 Jan.
3
Changes of melanocytic lesions inducedby Melanotan injections and sun bed use ina teenage patient with FAMMM syndrome.FAMMM 综合征青少年患者使用麦拉宁酮注射和晒床后黑素细胞病变的变化。
Dermatol Pract Concept. 2012 Jul 31;2(3):203a10. doi: 10.5826/dpc.0203a10. Print 2012 Jul.
4
Correlation between dermoscopic and histopathological diagnoses of atypical nevi in a dermatology outpatient clinic of the Medical School of São José do Rio Preto, SP, Brazil.巴西圣保罗州里奥普雷图河畔圣若泽医学院皮肤科门诊非典型痣的皮肤镜诊断与组织病理学诊断之间的相关性
An Bras Dermatol. 2013 Mar-Apr;88(2):199-203. doi: 10.1590/S0365-05962013000200002.
5
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.皮肤科医生对中重度银屑病治疗安全性和有效性的信念差异。
J Am Acad Dermatol. 2013 Feb;68(2):262-9. doi: 10.1016/j.jaad.2012.07.007. Epub 2012 Aug 19.
6
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.发育不良性痣:从历史视角到现代时代的管理:第二部分。分子方面和临床管理。
J Am Acad Dermatol. 2012 Jul;67(1):19.e1-12; quiz 31-2. doi: 10.1016/j.jaad.2012.03.013.
7
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.发育不良性痣:从历史角度到现代时代的管理:第一部分。历史、组织学和临床方面。
J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16; quiz 17-8. doi: 10.1016/j.jaad.2012.02.047.
8
HLA antigen expression in melanocytic lesions: is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?黑素细胞病变中的 HLA 抗原表达:获得 HLA 抗原表达是否是不典型(发育不良)黑素细胞的生物标志物?
J Am Acad Dermatol. 2012 Jun;66(6):911-6, 916.e1-8. doi: 10.1016/j.jaad.2011.04.025. Epub 2012 Mar 23.
9
Noninvasive genomic detection of melanoma.无创性黑色素瘤的基因组检测。
Br J Dermatol. 2011 Apr;164(4):797-806. doi: 10.1111/j.1365-2133.2011.10239.x. Epub 2011 Mar 25.
10
Cyclin D1 and D3 expression in melanocytic skin lesions.cyclin D1 和 D3 在黑色素细胞皮肤病变中的表达。
Arch Dermatol Res. 2010 Sep;302(7):545-50. doi: 10.1007/s00403-010-1054-3. Epub 2010 May 23.